# Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer

> **NCT00305760** · PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 60 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Cetuximab
- **BIOLOGICAL:** Pancreatic tumor vaccine
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT00305760
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00305760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00305760, "Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00305760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*